TUDCA trial did not meet its endpoints
April 04, 2024
An announcement of the top-line results from a European phase 3 clinical trial of TUDCA revealed that the primary endpoint of the study was not met as TUDCA failed to demonstrate an ability to significantly alter the progression of ALS…
Continue reading